selected publications
- The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study. Cancer. 2023 Academic Article GET IT
-
A multidisciplinary management algorithm for brain metastases.
Neuro-oncology advances.
2022
Review
GET IT
Times cited: 9 -
PI3K/Akt and Wnt/β-catenin Signaling Cross-regulate NF-κB Signaling in TNF-α-induced Human Lgr5+ Intestinal Stem Cells.
Anticancer research.
2022
Academic Article
GET IT
Times cited: 2 - Immune Checkpoint Blockade and Skin Toxicity Pathogenesis. The Journal of investigative dermatology. 2021 Review GET IT
-
The clinical development of obinutuzumab for the treatment of follicular lymphoma.
Cancer management and research.
2017
Review
GET IT
Times cited: 4 - The clinical development of obinutuzumab for the treatment of follicular lymphoma. Cancer management and research. 2017 Academic Article
- Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killing. Molecular Therapy. 2013 Academic Article
-
Targeted coating with antigenic peptide renders tumor cells susceptible to CD8(+) T cell-mediated killing.
Molecular therapy : the journal of the American Society of Gene Therapy.
2012
Academic Article
GET IT
Times cited: 14 -
Emerging human papillomavirus vaccines.
Expert opinion on emerging drugs.
2012
Review
GET IT
Times cited: 69 - Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine. 2012 Academic Article
- Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine. 2012 Academic Article GET IT
- Emerging human papillomavirus vaccines. 2012 Academic Article
- LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines. Vaccine. 2012 Academic Article
-
Development of a DNA vaccine targeting Merkel cell polyomavirus.
Vaccine.
2011
Academic Article
GET IT
Times cited: 51 -
LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines.
Vaccine.
2011
Academic Article
GET IT
Times cited: 41 -
DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity.
Cell & bioscience.
2011
Academic Article
GET IT
Times cited: 7 -
Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.
Cancer immunology, immunotherapy : CII.
2011
Academic Article
GET IT
Times cited: 15 -
HPV pseudovirions as DNA delivery vehicles.
Therapeutic delivery.
2011
Editorial Article
GET IT
Times cited: 10 - DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity. Cell and Bioscience. 2011 Academic Article
- HPV pseudovirions as DNA delivery vehicles. Therapeutic delivery. 2011 Academic Article
- Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors. 2011 Academic Article
-
Therapeutic HPV DNA vaccines.
Immunologic research.
2010
Review
GET IT
Times cited: 107 -
Immunotherapy for cervical cancer: Research status and clinical potential.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.
2010
Review
GET IT
Times cited: 99 - Immunotherapy for cervical cancer: Research status and clinical potential. Biodrugs. 2010 Academic Article
- Therapeutic HPV DNA vaccines. Immunologic research. 2010 Academic Article
-
Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer.
Molecular therapy : the journal of the American Society of Gene Therapy.
2009
Academic Article
GET IT
Times cited: 44 - Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer. Molecular Therapy. 2009 Academic Article
-
Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
Expert opinion on biological therapy.
2008
Review
GET IT
Times cited: 162